Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norihiko Kitagawa

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Pediatric Blood & Cancer|August 17, 2020
Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)Dai Keino, Tomoko Yokosuka, Ayana Hirose, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2022
A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastomaTakafumi Kondo, Shohei Honda, Hiromu Suzuki, et al.
Genes, Chromosomes & Cancer|October 14, 2024
Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell LineKeisuke Kato, Hiroaki Goto, Mio Tanaka, et al.
Pediatric Blood & Cancer|May 10, 2025
Treatment of Intermediate-Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical ResectionTomoro Hishiki, Kohmei Ida, Kenichiro Watanabe, et al.
Pediatric Blood & Cancer|August 10, 2024
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review systemIsamu Saeki, Kohmei Ida, Sho Kurihara, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Pediatric Blood & Cancer|August 17, 2020
Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)Dai Keino, Tomoko Yokosuka, Ayana Hirose, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2022
A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastomaTakafumi Kondo, Shohei Honda, Hiromu Suzuki, et al.
Genes, Chromosomes & Cancer|October 14, 2024
Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell LineKeisuke Kato, Hiroaki Goto, Mio Tanaka, et al.
Pediatric Blood & Cancer|May 10, 2025
Treatment of Intermediate-Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical ResectionTomoro Hishiki, Kohmei Ida, Kenichiro Watanabe, et al.
Pediatric Blood & Cancer|August 10, 2024
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review systemIsamu Saeki, Kohmei Ida, Sho Kurihara, et al.
Pageof 5